We tested the hypothesis that erythropoietin (EPO) enhances bone formation after posterolateral spinal fusion (PLF) in a rabbit model. Thirty-four adult rabbits underwent posterolateral intertransverse arthrodesis at the L5-L6 level using 2.0ag autograft per side. The animals were randomly divided into two groups receiving subcutaneous daily injections of either EPO or saline for 20 days. Treatment commenced 2 days preoperatively. Hemoglobin was monitored at baseline and 2, 4, and 6 weeks after fusion surgery. After euthanasia 6 weeks postoperatively, manual palpation, radiographic, and histomorphometric examinations were performed. Bone volume of the fusion mass was estimated by CT after 6 weeks. EPO increased bone fusion volume to 3.85accm (3.66-4.05) compared with 3.26accm (2.97-3.55) in the control group (pa
CITATION STYLE
Rölfing, J. H. D., Bendtsen, M., Jensen, J., Stiehler, M., Foldager, C. B., Hellfritzsch, M. B., & Bünger, C. (2012). Erythropoietin augments bone formation in a rabbit posterolateral spinal fusion model. Journal of Orthopaedic Research, 30(7), 1083–1088. https://doi.org/10.1002/jor.22027
Mendeley helps you to discover research relevant for your work.